HIGH GRADE SEROUS ADENOCARCINOMA OF OVARY
Clinical trials for HIGH GRADE SEROUS ADENOCARCINOMA OF OVARY explained in plain language.
Never miss a new study
Get alerted when new HIGH GRADE SEROUS ADENOCARCINOMA OF OVARY trials appear
Sign up with your email to follow new studies for HIGH GRADE SEROUS ADENOCARCINOMA OF OVARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental cancer drug enters first human trials for Tough-to-Treat gynecologic cancers
Disease control OngoingThis early-stage study is testing a new drug called IMGN151 in patients with recurrent gynecologic cancers that have returned after previous treatments. The main goals are to determine the safest dose, understand how the drug behaves in the body, and see if it shows any early sig…
Matched conditions: HIGH GRADE SEROUS ADENOCARCINOMA OF OVARY
Phase: PHASE1 • Sponsor: AbbVie • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Scientists test new pill to fight tough ovarian cancer
Disease control OngoingThis study aims to find the best dose of a new oral drug called sovilnesib for people with advanced ovarian cancer that has stopped responding to standard platinum-based chemotherapy. About 120 participants will take different doses to see which one is safest and shows the most p…
Matched conditions: HIGH GRADE SEROUS ADENOCARCINOMA OF OVARY
Phase: PHASE1 • Sponsor: Volastra Therapeutics, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC